#Japan #Tokyo #HOPECELL #Stem Cell Institute #Umbilical Cord Blood

A Milestone in Medical Storage: Stem Cell Institute's 5-Year Anniversary

The Stem Cell Institute, headquartered in Minato, Tokyo, has established itself as a leader in the biobanking sector, focusing on the storage of umbilical cord and cord blood. As they approach the fifth anniversary of their listing on the Tokyo Stock Exchange on June 25, 2026, the company is committed to expanding options for families preparing for the future of medicine.

With a robust network of obstetric medical facilities across the nation, and an established system for the safe transport and storage of precious stem cells, the company ensures reliable long-term preservation. The growing interest in regenerative medicine and cellular therapies has prompted an increase in families considering the preservation of cord blood and tissue as a viable choice for future medical options.

As part of their anniversary celebrations, the Stem Cell Institute will introduce the renewed cord and cord blood storage service branded as HOPECELL in November 2024. From December 2025, the company will conduct the HOPECELL First Anniversary Campaign, which offers five years of storage fees for free, valued at up to 66,000 yen. The company has seen remarkable feedback and has assisted numerous families in utilizing this essential service.

This campaign, in response to public interest and customer satisfaction, will continue under the name Tokyo Stock Exchange 5th Anniversary Campaign, providing an opportunity for families to secure future medical choices for their children.

Details of the 5th Anniversary Campaign

• - Campaign Period: March 25, 2026, 3:00 PM to June 30, 2026, 5:00 PM
• - Eligibility: Families signing a contract for HOPECELL during the campaign period
• - Discount: Five years of free storage fees for 10 or 20-year plans (maximum 66,000 yen)

This campaign is a continuation of the successful HOPECELL First Anniversary Campaign, aiming to make the option of preparing for the future medical needs of children more accessible for many families.

What is HOPECELL?

HOPECELL is the only service in Japan that offers the combined storage of umbilical cord and cord blood. Many families are opting for this service as they consider it a necessary choice for future healthcare needs.

Key Features:

• - High probability of preserving either umbilical cord or cord blood due to their simultaneous collection.
• - Affordable monthly storage fees starting from 2,980 yen, making it a financially accessible choice.
• - No additional fees for installment payments, allowing families to utilize the service without interest burden.

The Potential of Umbilical Cord and Blood

Umbilical cord and cord blood are rich in stem cells, leading to increasing research and applications that utilize their unique properties.

• - They are being utilized in clinical research targeting conditions like cerebral palsy and autism spectrum disorder (ASD).
• - Research continues to develop iPS cells derived from personal sources, known as autologous iPS cells.
• - Cord-derived stem cell culture supernatant, known as Family Supernatant®, is available for family use, ensuring wider applications of these precious cells.

Company Overview

The Stem Cell Institute operates under the corporate slogan, Providing New Medical Choices for New Lives, leveraging a strong network with obstetric facilities for its biobanking operations. They aim to drive global and sustainable growth and social contribution through the development of new treatment methodologies utilizing perinatal-derived cells like umbilical cord and cord blood, as well as investments in regenerative medicine and femtech sectors.

• - Established: August 5, 1999 (Tokyo Stock Exchange Growth Market: 7096)
• - Capital: 707 million yen
• - CEO: Takafumi Shimizu
• - Head Office: 2nd floor, Tokyu Toranomon Building, 1-21-19 Toranomon, Minato, Tokyo 105-0001, Japan
• - Contact: Website | Tel: 03-6811-3230
• - Group Companies: STEMCELL INNOVATIONS PTE. LTD. (Singapore), Milcare Inc.